linkedin Created with Sketch. twitter Created with Sketch. instagram Created with Sketch.
Shape
← Back to portfolio Porfolio / Arcinova

Arcinova

Pharmaceutical research and development company

Company overview

Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.

Website
arcinova.uk

This is an exciting time for Arcinova. We have a fantastic team,​ a world-class facility and strong market opportunity. ​We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on​ a period of capital expenditure and international expansion.

Professor Ian Shott​, executive chair

Company information

Head office
  • Alnwick, Northumberland
CEO
  • Professor Ian Shott
Chair
BGF office
BGF team
Investment date
  • Jun 2018 - Feb 2021
Total BGF investment
  • £5 million

Business funding insights

March 2021 Insights

BGF explains: initial public offerings (IPOs)

We explain what’s meant by an initial public offering (IPO), also known as listing or ‘going public’.
Business funding
March 2021 Insights

When to pursue debt refinancing and why

You may find that refinancing or renegotiating your business debts can put you in a stronger financial position. Look at…
Business funding
March 2021 Insights

Women who lead growing businesses: a survey

Our research reveals female entrepreneurs in the growth economy are concerned about the pandemic and Brexit, but remain resilient and motivated to achieve growth
Business funding